Protein kinases as targets for anticancer agents: from inhibitors to useful drugs.

dc.contributor.authorFabbro, Doriano
dc.contributor.authorRuetz, S.
dc.contributor.authorBuchdunger, E.
dc.contributor.authorCowan-Jacob, S. W.
dc.contributor.authorFendrich, G.
dc.contributor.authorLiebetanz, J.
dc.contributor.authorMestan, J.
dc.contributor.authorO'Reilly, T.
dc.contributor.authorTraxler, P.
dc.contributor.authorChaudhuri, B.
dc.contributor.authorFretz, Heinz
dc.contributor.authorZimmermann, J.
dc.contributor.authorMeyer, T.
dc.contributor.authorCaravatti, G.
dc.contributor.authorFuret, Pascal
dc.contributor.authorManley, P. W.
dc.date.accessioned2009-11-06T14:26:14Z
dc.date.available2009-11-06T14:26:14Z
dc.date.issued2002
dc.identifier.citationFabbro D, Ruetz S, Buchdunger E, Cowan-Jacob SW, Fendrich G, Liebetanz J, Mestan J, O'Reilly T, Traxler P, Chaudhuri B, Fretz H, Zimmermann J, Meyer T, Caravatti G, Furet P, Manley PW. (2002) Protein kinases as targets for anticancer agents: from inhibitors to useful drugs. Pharmacology and Therapeutics. 93 (2-3), pp. 79-98.en
dc.identifier.doihttps://doi.org/10.1016/S0163-7258(02)00179-1
dc.identifier.issn0163-7258
dc.identifier.urihttp://hdl.handle.net/2086/2803
dc.language.isoenen
dc.peerreviewedYesen
dc.publisherElsevieren
dc.researchgroupChemistry for Health
dc.titleProtein kinases as targets for anticancer agents: from inhibitors to useful drugs.en
dc.typeArticleen

Files

License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.25 KB
Format:
Item-specific license agreed upon to submission
Description: